From: A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors
Laboratory
Risk score
parameter
0 point
1 point
Hemoglobin (g/L)
≥ 120
< 120
Platelet count (E9/L)
≤ 360
> 360
Neutrophil count (E9/L)
≤ 7.5
> 7.5
CRP (mg/L)
≤ 3
> 3
ESR (mm/h)
≤ 20
> 20
LDH (U/L)
≤ 205
> 205